340B Advocacy Alliance Bulletin
Eli Lilly Moves to Deny 340B Pricing Over Data Requirements; AHA Urges Federal Action
Memo provides details of new CVS 340B contract pharmacy amendment — please share the memo with your legal team
DEADLINE EXTENDED: Complete 340B survey by June 5.
REMINDER: AHA seeks hospital input on scope of drug company 340B data policy compliance by May 26 deadline.
Complete AHA Survey by May 28 on Drug Company 340B Data Policy Compliance
AHA urges Lilly to drop 340B claims-data policy, proposes neutral clearinghouse.
AHA pushes back on WSJ anti-340B editorial.
Washington Post publishes AHA letter in response to anti-340B editorial
AHA Comments on 340B Rebate Model RFI.
AHA responds to Washington Post editorial on 340B program.